Click on a filter below to refine your search. Remove a filter to broaden your search.
HHS is rapidly expanding access to hundreds of thousands of doses of the Jynneos vaccine.
Both Pfizer and Moderna have been testing updated booster shots that target the omicron variant.
The vaccine targets both omicron and the original strain of the virus.
However, breakthrough infections among J&J vaccine recipients were similar or lower compared with the other vaccines.
The Moderna vaccine is the second COVID-19 vaccine to receive full approval from both the FDA and CDC.
Vaccine, which has been available for the age group under emergency use authorization, will be marketed as Spikevax.
The new study will focus on a single omicron-specific booster dose in about 600 adults.
The court also was hearing arguments on separate vaccine mandate for most heathcare workers.
Included in the battle plan announced Tuesday are measures to distribute 500 million free rapid COVID-19 tests to the public.
Experts agree that booster shots are the best defense against the omicron variant of COVID-19.